Results 111 to 120 of about 6,525 (155)

Small-Molecule-Induced Protein Polymerization: Mechanisms and Therapeutic Implications. [PDF]

Biomol Ther (Seoul)
Hah YS, Han SY.
europepmc   +1 more source

Notch-1 suppressed vascular dementia via modulating AMPK/mTOR/TFEB/YAP signaling induced ferroptosis. [PDF]

Eur J Med Res
Zhu L, Wu Z, Zhang Z, Liu F, Zhang J, Qian X, Zheng Y.   +6 more
europepmc   +1 more source

Reduced-fluence photodynamic therapy versus placebo for central serous chorioretinopathy (REPLAY trial): rationale and study protocol of a pivotal double-blind randomised controlled trial. [PDF]

BMJ Open
Miyake M, Takahashi A, Baba T, Maruko I, Ohnaka M, Kuroda A, Tada H, Hidaka Y, Ibi Y, Muraoka Y, Ito T, Morita S, Sakamoto T, Imai H, Yamamoto S, Iida T, Tsujikawa A.   +16 more
europepmc   +1 more source

Hydrostatic pressure regulates glutamine metabolism to promote bladder fibroblast activation via the Piezo1/YAP1/GLS1 axis. [PDF]

J Transl Med
Li K, Wei P, Li Z, Kuang W, Zhang M, Luo C, Cui K, Lin D, Chen Z.   +8 more
europepmc   +1 more source

FGF2 alleviates LPS-induced acute lung injury by inhibiting ferritinophagy-mediated ferroptosis in AT2 cells via the Hippo-YAP signaling pathway. [PDF]

Front Immunol
Wang Y, Zhu P, Ding Y, Han X, Wang X, Wu S, Huai S, Li N, Xu G, Du Y.   +9 more
europepmc   +1 more source

Identifying the Role of YAP in the Development of Rumen Epithelium Using 3D Organoid. [PDF]

Stem Cells Int
Xu Z, Xu X, Mi Y, Zhang Y, Hong Q, Yang B, Wang J.   +6 more
europepmc   +1 more source

Targeting BMP and TAZ/TEAD mechanotransduction pathways impairs acute myeloid leukemia chemoresistance. [PDF]

Leukemia
Barral L, Lespinasse N, Martin Cardozo C, Jeanpierre S, Bourgeois A, Rösel K, Beillard E, Laurent D, Peyrouze P, Belhabri A, Guillermin Y, Mazurier F, Cheok M, Audry-Deschamps MC, Faivre M, Maguer-Satta V, Lefort S.   +16 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Verteporfin

Drugs, 2012
Susan J Keam, Lesley J Scott, Monique P Curran   +2 more
exaly   +7 more sources

Verteporfin

Drugs & Aging, 2000
Verteporfin, a benzoporphyrin derivative monoacid ring A, is a photosensitising drug for photodynamic therapy (PDT) activated by low-intensity, nonheat-generating light of 689nm wavelength. Activation generates cytotoxic oxygen free radicals. The specificity and uptake of verteporfin for target cells with a high expression of low density lipoprotein ...
L J, Scott, K L, Goa
  +5 more sources